Company intelligence / Profile preview

Pepceuticals

Leicester, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

Pepceuticals operates as a commercial GMP manufacturer of synthetic peptides and related services for drug development and clinical/commercial supply rather than as a therapeutics developer with its own clinical pipeline.[1][2][4]

Modalities: PeptidesMonoclonal antibodyPolyclonal antibodyBiologic
Industry: Contract Manufacturing Organization

Partnerships

Biosynth (acquisition and integration as part of Biosynth’s global peptide and biologics CDMO network)[1][2]

Beyond the preview

Go deeper on Pepceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pepceuticals.

Explore the full profile